$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!

Newlink Genetics Corporation
(NASDAQ : NLNK)

( )
NLNK PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading NLNK News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.68%81.471.6%$1008.08m
BIIBBiogen Inc.
0.43%318.171.2%$628.57m
AMGNAmgen Inc.
0.03%174.401.0%$523.71m
CELGCelgene Corporation
-0.17%114.010.8%$507.23m
MDVNMedivation, Inc.
-0.19%80.271.8%$360.64m
REGNRegeneron Pharmaceuticals, Inc.
0.47%420.613.4%$322.62m
ILMNIllumina, Inc.
-0.55%172.794.4%$241.54m
BMRNBioMarin Pharmaceutical Inc.
1.28%99.433.6%$206.66m
ALXNAlexion Pharmaceuticals, Inc.
0.65%137.422.6%$202.27m
VRTXVertex Pharmaceuticals Incorporated
0.03%100.992.3%$126.97m
EXASExact Sciences Corporation
-1.78%20.4330.9%$124.73m
IONSIonis Pharmaceuticals, Inc.
-0.47%33.7111.1%$99.57m
INCYIncyte Corporation
-0.10%81.902.6%$93.48m
AAgilent Technologies, Inc.
0.50%47.820.9%$91.87m
TSROTESARO, Inc.
-6.39%92.7615.8%$88.11m

Company Profile

NewLink Genetics Corp. is a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians. Its portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. The company's products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189 and IDO Pathway Inhibitors. NewLink Genetics was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA.